{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:54:02Z","timestamp":1790855642150,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.aohep.2019.06.022","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T11:28:36Z","timestamp":1569324516000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations"],"prefix":"10.1016","volume":"19","author":[{"given":"Mar\u00eda-Jimena","family":"Muci\u00f1o-Bermejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0405","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jceh.2017.12.005","article-title":"Renal dysfunction in patients with nonalcoholic fatty liver disease is related to the presence of diabetes mellitus and severity of liver disease","volume":"9","author":"Nampoothiri","year":"2019","journal-title":"J Clin Exp Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2019.06.022_bib0410","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molmed.2015.08.005","article-title":"Emerging liver-kidney interactions in nonalcoholic fatty liver disease","volume":"21","author":"Musso","year":"2015","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0415","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5527\/wjn.v4.i1.74","article-title":"ACE and ACE2 in kidney disease","volume":"4","author":"Mizuiri","year":"2015","journal-title":"World J Nephrol"},{"key":"10.1016\/j.aohep.2019.06.022_bib0420","doi-asserted-by":"crossref","first-page":"587140","DOI":"10.1155\/2013\/587140","article-title":"Effect of telmisartan or losartan for treatment of nonalcoholic fatty liver disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)","volume":"2013","author":"Hirata","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.aohep.2019.06.022_bib0425","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.med.60.101107.134820","article-title":"Emerging molecular targets for the treatment of nonalcoholic fatty liver disease","volume":"61","author":"Musso","year":"2010","journal-title":"Annu Rev Med"},{"issue":"28\u201341","key":"10.1016\/j.aohep.2019.06.022_bib0430","article-title":"Caloric restriction, resveratrol and melatonin: role of SIRT1 and implications for aging and related-diseases","volume":"146\u2013148","author":"Ramis","year":"2015","journal-title":"Mech Ageing Dev"},{"issue":"7\u20138","key":"10.1016\/j.aohep.2019.06.022_bib0435","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.nut.2013.11.016","article-title":"Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation","volume":"30","author":"Andrade","year":"2014","journal-title":"Nutrition"},{"issue":"8","key":"10.1016\/j.aohep.2019.06.022_bib0440","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/mnfr.201500016","article-title":"Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway","volume":"59","author":"Zhang","year":"2015","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"10.1016\/j.aohep.2019.06.022_bib0445","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm.3363","article-title":"Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes","volume":"19","author":"Hasegawa","year":"2013","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0450","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ki.2014.217","article-title":"High-mobility group box 1 is a novel deacetylation target of Sirtuin1","volume":"87","author":"Rabadi","year":"2015","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.aohep.2019.06.022_bib0455","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0460","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog Lipid Res"},{"issue":"2","key":"10.1016\/j.aohep.2019.06.022_bib0465","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11906-012-0250-2","article-title":"Lipid nephrotoxicity: new concept for an old disease","volume":"14","author":"Gyebi","year":"2012","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"10.1016\/j.aohep.2019.06.022_bib0470","doi-asserted-by":"crossref","first-page":"F1587","DOI":"10.1152\/ajprenal.00404.2009","article-title":"The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria","volume":"297","author":"Wang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.aohep.2019.06.022_bib0475","doi-asserted-by":"crossref","first-page":"F266","DOI":"10.1152\/ajprenal.00482.2011","article-title":"ER stress contributes to renal proximal tubule injury by increasing SREBP-2-mediated lipid accumulation and apoptotic cell death","volume":"303","author":"Lhotak","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9972","key":"10.1016\/j.aohep.2019.06.022_bib0480","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.aohep.2019.06.022_bib0485","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ndt\/gfs350","article-title":"Dysregulation of hepatic fatty acid metabolism in chronic kidney disease","volume":"28","author":"Jin","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0490","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.aohep.2019.06.022_bib0495","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/snep.2002.33671","article-title":"Beyond hepatorenal syndrome: glomerulonephritis in patients with liver disease","volume":"22","author":"Lhotta","year":"2002","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.aohep.2019.06.022_bib0500","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1053\/j.ajkd.2010.08.018","article-title":"Spontaneous remission of IgA nephropathy associated with resolution of hepatitis A","volume":"56","author":"Han","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0505","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jcv.2011.07.013","article-title":"Clinical features and outcomes of acute kidney injury among patients with acute hepatitis A","volume":"52","author":"Choi","year":"2011","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.aohep.2019.06.022_bib0510","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1111\/j.1651-2227.2011.02231.x","article-title":"Fulminant hepatitis and glomerulonephritis \u2013 a rare presentation of hepatitis A virus infection","volume":"100","author":"Pal","year":"2011","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.aohep.2019.06.022_bib0515","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1990.32","article-title":"Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations","volume":"37","author":"Johnson","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.aohep.2019.06.022_bib0520","first-page":"S40","article-title":"Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults","volume":"35","author":"Lai","year":"1991","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"10.1016\/j.aohep.2019.06.022_bib0525","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2215\/CJN.09180816","article-title":"Viral-associated GN: hepatitis B and other viral infections","volume":"12","author":"Kupin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.aohep.2019.06.022_bib0530","first-page":"S24","article-title":"Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s","volume":"35","author":"Levy","year":"1991","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.aohep.2019.06.022_bib0535","unstructured":"Tak-Mao C, Lok A. Renal disease associated with hepatitis B virus infection. Glassock RJ, Bisceglie AM, ed. UpToDate. Waltham, MA: UpToDate Inc. http:\/\/www.uptodate.com [accessed 10.10.18]."},{"issue":"6","key":"10.1016\/j.aohep.2019.06.022_bib0540","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/ki.1996.519","article-title":"Detection of hepatitis B virus DNA and RNA in kidneys of HBV related glomerulonephritis","volume":"50","author":"Lai","year":"1996","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.aohep.2019.06.022_bib0545","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/ndt\/gfp737","article-title":"A role for MHBst167\/HBx in hepatitis B virus-induced renal tubular cell apoptosis","volume":"25","author":"Hong","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.aohep.2019.06.022_bib0550","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1743-422X-10-300","article-title":"Purified hepatitis B virus induces human mesangial cell proliferation and extracellular matrix expression in vitro","volume":"10","author":"Diao","year":"2013","journal-title":"Virol J"},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0555","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/icb.2015.85","article-title":"Hepatitis B virus X protein modulates renal tubular epithelial cell-induced T-cell and macrophage responses","volume":"94","author":"Wang","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.aohep.2019.06.022_bib0560","unstructured":"Kamar, N., Rostaing L. Overview of renal disease associated with hepatitis C virus infection. Glassock, Hirsch MS. Ed. UpToDate. Waltham, MA: UpToDate Inc. http:\/\/www.uptodate.com [accessed 10.10.18]."},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0565","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/hep.29192","article-title":"Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2019.06.022_bib0570","doi-asserted-by":"crossref","first-page":"17086","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis E virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0575","first-page":"1","article-title":"Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature","volume":"4","author":"Bazerbachi","year":"2016","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"10","key":"10.1016\/j.aohep.2019.06.022_bib0580","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI102813","article-title":"The cardiac output at rest in Laennec's cirrhosis","volume":"32","author":"Kowalski","year":"1953","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000492791","article-title":"Hepatorenal syndrome or hepatocardiorenal syndrome: revisiting basic concepts in view of emerging data","volume":"9","author":"Kazory","year":"2019","journal-title":"Cardiorenal Med"},{"issue":"2","key":"10.1016\/j.aohep.2019.06.022_bib0590","doi-asserted-by":"crossref","first-page":"e7809","DOI":"10.1590\/1414-431x20187809","article-title":"Cirrhotic cardiomyopathy: the liver affects the heart","volume":"52","author":"Carvalho","year":"2019","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0595","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","article-title":"Cirrhotic cardiomyopathy: pathogenesis and clinical relevance","volume":"11","author":"Wiese","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2019.06.022_bib0600","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jjcc.2015.08.001","article-title":"A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation","volume":"67","author":"Chen","year":"2016","journal-title":"J Cardiol"},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0605","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ultrasmedbio.2017.11.013","article-title":"New definition criteria of myocardial dysfunction in patients with liver cirrhosis: a speckle tracking and tissue Doppler imaging study","volume":"44","author":"Rimbas","year":"2018","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0610","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heart.87.1.9","article-title":"Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease","volume":"87","author":"Moller","year":"2002","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0615","first-page":"31","article-title":"Cardiovascular dysfunction in patients with liver cirrhosis","volume":"28","author":"Fede","year":"2015","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0620","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mehy.2012.03.032","article-title":"The cardiorenal link in advanced cirrhosis","volume":"79","author":"Krag","year":"2012","journal-title":"Med Hypotheses"},{"issue":"7","key":"10.1016\/j.aohep.2019.06.022_bib0625","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.aohep.2019.06.022_bib0630","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00365510152567059","article-title":"Vasoactive substances in the circulatory dysfunction of cirrhosis","volume":"61","author":"Moller","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"issue":"9","key":"10.1016\/j.aohep.2019.06.022_bib0635","doi-asserted-by":"crossref","first-page":"F1253","DOI":"10.1152\/ajprenal.00392.2012","article-title":"Target organ cross talk in cardiorenal syndrome: animal models","volume":"303","author":"Bongartz","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"10.1016\/j.aohep.2019.06.022_bib0640","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure","volume":"60","author":"Ronco","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.aohep.2019.06.022_bib0645","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.aohep.2019.06.022_bib0650","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000349969","article-title":"Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Haase","year":"2013","journal-title":"Contrib Nephrol"},{"issue":"12","key":"10.1016\/j.aohep.2019.06.022_bib0655","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cardfail.2014.09.005","article-title":"Cardiorenal interactions in acute decompensated heart failure: contemporary concepts facing emerging controversies","volume":"20","author":"Kazory","year":"2014","journal-title":"J Card Fail"},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0660","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2007.11.012","article-title":"Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis","volume":"48","author":"Zambruni","year":"2008","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0665","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.aohep.2019.06.022_bib0670","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/MEG.0b013e3283367a99","article-title":"The role of carvedilol in the management of portal hypertension","volume":"22","author":"Tripathi","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0675","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005344-200501000-00003","article-title":"Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist","volume":"45","author":"Bos","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0680","first-page":"4","article-title":"Evaluation of chronic losartan treatment effect on cardiac chronotropic dysfunction in biliary cirrhotic rats","volume":"56","author":"Jazaeri","year":"2018","journal-title":"Acta Med Iran"},{"issue":"5","key":"10.1016\/j.aohep.2019.06.022_bib0685","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1572-0241.2005.41060.x","article-title":"Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis","volume":"100","author":"Pozzi","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.aohep.2019.06.022_bib0690","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.25915","article-title":"New therapeutic paradigm for patients with cirrhosis","volume":"56","author":"Tsochatzis","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0695","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhep.2004.09.008","article-title":"Cardiac alterations in cirrhosis: reversibility after liver transplantation","volume":"42","author":"Torregrosa","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2019.06.022_bib0700","doi-asserted-by":"crossref","first-page":"2354253","DOI":"10.1155\/2017\/2354253","article-title":"Evaluation of adrenal function in nonhospitalized patients with cirrhosis","volume":"2017","author":"Moini","year":"2017","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2019.06.022_bib0705","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10620-017-4471-8","article-title":"Relative adrenal insufficiency in patients with cirrhosis: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.aohep.2019.06.022_bib0710","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1097\/CCM.0000000000000544","article-title":"Critical illness-related corticosteroid insufficiency in cirrhotic patients with acute gastroesophageal variceal bleeding: risk factors and association with outcome","volume":"42","author":"Tsai","year":"2014","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.aohep.2019.06.022_bib0715","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.21101","article-title":"Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock","volume":"43","author":"Tsai","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0720","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12072-014-9581-1","article-title":"Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction","volume":"9","author":"Risor","year":"2015","journal-title":"Hepatol Int"},{"issue":"9","key":"10.1016\/j.aohep.2019.06.022_bib0725","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1478-3231.2011.02751.x","article-title":"Cardiac dysfunction in cirrhosis \u2013 does adrenal function play a role? A hypothesis","volume":"32","author":"Theocharidou","year":"2012","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.aohep.2019.06.022_bib0730","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.26535","article-title":"Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death","volume":"58","author":"Acevedo","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2019.06.022_bib0735","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3748\/wjg.v19.i4.445","article-title":"Update on adrenal insufficiency in patients with liver cirrhosis","volume":"19","author":"Trifan","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.aohep.2019.06.022_bib0740","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/liv.12788","article-title":"Relative adrenal insufficiency in severe acute variceal and non-variceal bleeding: influence on outcomes","volume":"35","author":"Graupera","year":"2015","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.aohep.2019.06.022_bib0745","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0676.2003.00813.x","article-title":"The effects of supraphysiological doses of corticosteroids in hypotensive liver failure","volume":"23","author":"Harry","year":"2003","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.aohep.2019.06.022_bib0750","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/01.CCM.0000164541.12106.57","article-title":"The hepatoadrenal syndrome: a common yet unrecognized clinical condition","volume":"33","author":"Marik","year":"2005","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.aohep.2019.06.022_bib0755","first-page":"103","article-title":"Glomerulonephritis associated with arteritis in marmosets infected with hepatitis A virus","volume":"62","author":"Morita","year":"1981","journal-title":"Br J Exp Pathol"},{"issue":"6","key":"10.1016\/j.aohep.2019.06.022_bib0760","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5414\/CN107615","article-title":"Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy","volume":"78","author":"Li","year":"2012","journal-title":"Clin Nephrol"},{"issue":"4\u20135","key":"10.1016\/j.aohep.2019.06.022_bib0765","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000431331","article-title":"Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy","volume":"41","author":"Xie","year":"2015","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.aohep.2019.06.022_bib0770","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","article-title":"Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients","volume":"74","author":"Guillevin","year":"1995","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.aohep.2019.06.022_bib0775","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/00007890-199706150-00017","article-title":"Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients","volume":"63","author":"Morales","year":"1997","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0780","first-page":"141","article-title":"Hepatitis C virus associated membranous glomerulonephritis","volume":"44","author":"Stehman-Breen","year":"1995","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.aohep.2019.06.022_bib0785","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0272-6386(96)90260-7","article-title":"Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys","volume":"28","author":"Cosio","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.aohep.2019.06.022_bib0790","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3899\/jrheum.080874","article-title":"Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry)","volume":"36","author":"Ramos-Casals","year":"2009","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.aohep.2019.06.022_bib0795","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/acr.20381","article-title":"Hepatitis C virus-associated polyarteritis nodosa","volume":"63","author":"Saadoun","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.aohep.2019.06.022_bib0800","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2016.11.016","article-title":"Hepatitis E virus: infection beyond the liver?","volume":"66","author":"Pischke","year":"2017","journal-title":"J Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119322343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119322343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:39:01Z","timestamp":1761647941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119322343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1665268119322343"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2019.06.022","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2019.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}